One-pot synthesis, purification, and formulation of bionanoparticle-CpG oligodeoxynucleotide hepatitis B surface antigen conjugate vaccine via tangential flow filtration

Bioconjugate Chemistry

Volumn 18, Issue 2, 2007, Pages 285-288

  Raja, Krishnaswami ^a   McDonald, Ross ^b   Tuck, Stephen ^b   Rodriguez, Roberto ^b   Milley, Bob ^b   Traquina, Paula ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Dynavax Technologies Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; VIRUSES;

ANTIGEN CONJUGATE; BIONANOPARTICLES; CONJUGATE VACCINE; FILTRATION METHODS; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS; OLIGODEOXYNUCLEOTIDES; ONE-POT SYNTHESIS; SYNTHESIS AND CHARACTERIZATIONS; TANGENTIAL FLOW FILTRATIONS;

VACCINES;

BIONANOPARTICLE; CPG OLIGODEOXYNUCLEOTIDE; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; NANOPARTICLE; POLYMER; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTECHNOLOGY; CAPILLARY ZONE ELECTROPHORESIS; CHEMICAL MODIFICATION; FILTRATION; HEPATITIS B; HEPATITIS B VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOSTIMULATION; LIGHT SCATTERING; NANOTECHNOLOGY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SYNTHESIS; TANGENTIAL FLOW FILTRATION; TRANSMISSION ELECTRON MICROSCOPY; VACCINATION; VACCINE PRODUCTION; VIRUS HEPATITIS; VIRUS PARTICLE;

HEPATITIS B VIRUS;

EID: 33947652667     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc060118q     Document Type: Article

References (17)

1. Raja, K. S., and Wang, Q. (2004) Bionanoparticles. In Encyclopedia of Nanoscience and Nanotechnology (James A. S., Contescu, C., and Putyera, K., Eds.) pp 331-330, Marcel Dekker, New York.
2. Vriezema, D. M., Aragones, M. C., Elemans, J. A. A. W., Cornelissen, J. J. L. M., Rowan, A. E., and Nolte, R. J. M. (2005) Self-assembled nanoreactors. Chem. Rev. 105 (4), 1445-1489.
3. Douglas, T., and Young, M. (1998) Host-guest encapsulation of materials by assembled virus protein cages. Nature (London) 393 (6681), 152-155.
4. Douglas, T., and Young, M. (2006) Viruses: making friends with old foes. Science 312 (5775), 873-875.
5. Douglas, T., Strahle, E., Willits, D., Aitouchen, A., Libera, M., and Young, M. (2002) Protein engineering of a viral cage for constrained nanomaterials synthesis. Adv. Mater. 14 (6), 415-418.
6. Wang, Q., Lin, T., Tang, L., Johnson, J. E., and Finn, M. G. (2002) Icosahedral virus particles as addressable nanoscale building blocks. Angew. Chem., Int. Ed. 41 (3), 459-462.
7. Raja, K. S., Wang, Q., and Finn, M. G. (2003) Icosahedral virus particles as polyvalent carbohydrate display platforms. ChemBioChem 4 (12), 1348-1351.
8. Raja, K. S., Wang, Q., Gonzalez, M. J., Manchester, M., Johnson, J. E., and Finn, M. G. (2003) Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules 4 (3), 472-476.
9. Gupta, S. S., Raja, K. S., Kaltgrad, E., Strable, E., and Finn, M. G. (2005) Virus-glycopolymer conjugates by copper(I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. Chem. Commun. (34), 4315-4317.
10. Schlick, T. L., Ding, Z., Kovacs, E. W., and Francis, M. B. (2005) Dual-surface modification of the tobacco mosaic virus. J. Am. Chem. Soc. 127 (11), 3718-3723.
11. Schirmbeck, R., and Reimann, J. (2001) Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen. Biol. Chem. 382, 543-552.
12. Klinman, D. M. (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249-259.
13. Halperin, A. S., Nest, G. V., Smith, B., Abtahi, S., Whiley, H., and Eiden, J. J. (2003) A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant, Vaccine 21, 2461-2467.
14. Dalwadi, G., Benson, H. A. E., and Chen, Y. Comparison of diafiltration and tangential flow filtration for purification of nano-particle suspensions (2005) Pharm. Res. 22 (12), 2152-2162.
15. Wickramasinghe, S. R., Kalbfuss, B., Zimmermann, A., Thom, V., and Reichl, U. (2005) Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification, Biotechnol. Bioeng. 92 (2), 199-208.
16. Morenweiser, R. (2005) Downstream processing of viral vectors and vaccines, Gene Ther. 12, S62-S72.
17. Yamaguchi, M., Sugahara, K., Shiosaki, K., Mizokami, H., and Takeo, K. (1998) Fine structure of hepatitis B virus surface antigen produced by recombinant yeast: comparison with HBsAg of human origin. FEMS Microbiol. Lett. 165 (2), 363.